Inventor
BALDWIN R MICHAEL
US3 patents
Patents
3 patentsUS10472335B2Nov 12, 2019
Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
THERAVANCE BIOPHARMA R&D IP LLC4 citations82
US11718591B2Aug 8, 2023
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereof
THERAVANCE BIOPHARMA R&D IP LLC1 citations70
US12351561B2Jul 8, 2025
Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
THERAVANCE BIOPHARMA R&D IP LLC0 citations60